Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
About Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
Company Facts
- Headquarters
- Lexington
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $280,800,008
- Last Funding Type
- series_b
- Last Funding Date
- 2025-12-03
- Website
- trianabio.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/triana-biomedicines-12075 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.